Business
Practice ManagementMalpractice ConsultHealth Law & Policy
Media
Case-Based Peer PerspectivesInvestigator Perspectives Medical World NewsPodcastsUrology Medical PerspectivesUTv VideosPeer ExchangeSpecial ReportVirtual Tumor BoardClinical Forum InsightsInsightsMedcastPeers & Perspectives
Conferences
Conference ListingConference Previews Conference Recaps
Publications
Urology Times JournalEditorial Advisory BoardUrologists in Cancer CareSupplements and Featured PublicationsClinical Forums Recaps
More
CME/CE
Resources
Begin Your Journey: Tackling BurnoutSponsored MediaLive EventsInteractive ToolsJob BoardPartnersSponsored ResourcesTreatment Landscape Evolutions

Subscribe

  • Business
  • Media
  • Conferences
  • Publications
  • CME/CE
  • Resources
  • Subscribe
  • Benign Conditions
  • Benign Prostatic Hyperplasia
  • Bladder Cancer
  • Female Urology
  • Genitourinary Cancers
  • Genomic Testing
  • Hormone Therapy
  • Kidney Cancer
  • Kidney Stones
    • Challenging Anatomy
  • Men's Health
  • Next-Generation Imaging
  • OAB and Incontinence
    • Voiding Dysfunction
  • Pediatrics
  • Prostate Cancer
    • Controveries in Urologic Cancer
    • Drug Therapy
  • Sexual Dysfunction
  • UTUC
  • Urologic Surgery
    • Cosmetic Surgery
Spotlight -
Peer Exchange|
Peers and Perspectives|
Case-Based Peer Perspectives|
Urology Times Journal
Advertisement

Daniel Au, MD

Advertisement

Articles by Daniel Au, MD

Photo courtesy of InTouch Health

How artificial intelligence may reshape urologic practice

ByDaniel Au, MD,J. Brantley Thrasher, MD
January 14th 2019

AI is poised to revolutionize use of medical data, but challenges remain.

Advertisement

Latest Updated Articles

  • Photo courtesy of InTouch Health
    How artificial intelligence may reshape urologic practice

    Published: January 14th 2019 | Updated:



Advertisement
Advertisement

Trending on Urology Times

1

Veda Giri, MD, on patient-reported outcomes with prostate cancer genetic testing

2

Cooled laser focal therapy shows promise for localized prostate cancer

3

John Sfakianos, MD, on dual immune checkpoint inhibition in NMIBC

4

Annual ACS NCDB report details national trends in prostate cancer care

5

Ridwan I. Alam, MD, MPH, discusses integrating PHI into prostate cancer diagnostic pathways

  • About Us
  • Advertise
  • Editorial
  • Contact Us
  • Job Board
  • Terms and Conditions
  • Privacy
  • Do not sell my Personnal Information
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us